Jeffrey Meckler - Jan 26, 2022 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CEO and Director, Director
Signature
/s/ Jeffrey Meckler
Stock symbol
INDP
Transactions as of
Jan 26, 2022
Transactions value $
$0
Form type
4
Date filed
1/28/2022, 03:30 PM
Previous filing
Nov 19, 2021
Next filing
May 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +200K $0.00 200K Jan 26, 2022 Common Stock 200K $4.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.